Skip to main content

Thomas J. Hornyak, MD, PhD

Academic Title:

Clinical Associate Professor

Primary Appointment:

Dermatology

Secondary Appointment(s):

BioChemistry&Molecular Biology

Location:

419 West Redwood Street, Suite 235

Phone (Primary):

667-214-1199

Education and Training

  • Princeton University, A.B., Music, 1985
  • The University of Michigan, M.D., Ph.D., Medicine, Biological Chemistry, 1992
  • The New York Hospital-Cornell University Medical Center, Medicine, Internshi,  1993
  • New York University Medical Center, Dermatology, Residency, 1996
  • New York University Medical Center, Post-doctoral fellowship, 1998

Biosketch

Dr. Thomas Hornyak is an internationally recognized physician scientist in pigment cell biology, melanoma and skin cancer. His current position titles are Chair, Department of Dermatology, VA Maryland Health Care System; Associate Professor of Dermatology and Biochemistry and Molecular Biology, University of Maryland School of Medicine;and  Associate Chief of Staff for Research & Development, VA Maryland Health Care System.

FolIowing completion of a Ph.D. in Biological Chemistry emphasizing enzymology and medical training, Dr. Hornyak completed a residency in clinical dermatology and began research on melanocytes as a post-doctoral fellow at New York University. At NYU, Dr. Hornyak described both the transcriptional biochemistry and the developmental determinants of early melanocyte development in the embryo. He completed this work as an independent investigator at the Henry Ford Health System in Detroit. 

Dr. Hornyak extended his work in developmental pigment cell biology to melanocyte stem cells and melanoma epigenetics in the Dermatology Branch of the National Cancer Institute, where he developed a transgenic mouse system to isolate and characterize melanocyte stem cells. At the National Cancer Institute, he developed a clinical protocol utilizing digital dermatoscopy to image selected melanocytic nevi on melanoma-prone patients in a serial manner, using clinical samples of nevi and melanoma to define the role of the Polycomb protein and histone methyltransferase EZH2 in suppressing senescence in melanoma cells.

Research/Clinical Keywords

Melanocyte stem cell differentiation and fate determination as well as melanoma epigenetics

Highlighted Publications

Hornyak, T. J., Bishop, P. D., & Shafer, J. A. "a-Thrombin-Catalyzed Activation of Human Platelet Factor XIII: Relationship between Proteolysis and Factor XIIIa Activity"  (1989) Biochemistry 28, 7326-7332.

Hornyak, T. J., & Shafer, J. A. "Role of Calcium Ion in the Generation of Factor XIII Activity" (1991) Biochemistry 30, 6175-6182.

Hornyak, T. J., & Shafer, J. A. "Interactions of Factor XIII with Fibrin as Substrate and Cofactor"  (1992) Biochemistry 31,  423-429.

Hornyak, T.J., Hayes, D. H., & Ziff, E.B. "Cell Density-Dependent Regulation of Expression and Glycosylation of Dopachrome Tautomerase/Tyrosinase-Related Protein-2 (TRP-2)" (2000)  Journal of Investigative Dermatology 115, 106-112.

Hornyak, T.J., Hayes, D.H., Chiu, L.-Y., & Ziff, E.B. "Transcription Factors in Melanocyte Development: Distinct Roles for Pax-3 and Mitf". (2001) Mechanisms of Development 101, 41-53.

Additional Publication Citations

Awards and Affiliations

Professional Activity

×